Abstract
Association between pulmonary function tests (PFTs) and non-alcoholic fatty liver disease (NAFLD) has been reported in adult studies; however, there is lack of pediatric studies. Our study aimed to evaluate PFTs in children with NAFLD. A total of 137 children with NAFLD and 100 healthy children of matched age and sex were included in the study. Different PFTs including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, residual volume (RV), and total lung capacity (TLC) were performed for all included children. Lipid profile, insulin resistance, fasting and postprandial glucose level, and high sensitive C reactive protein (hs-CRP) were measured. FEV1 %, FVC %, FEV1/FVC ratio, RV, and TLC were significantly lower in the patient group compared with the control group (P < 0.05), while RV and hs-CRP were significantly higher in children with NAFLD. Restrictive lung dysfunction was the commonest pulmonary dysfunction detected in children with NAFLD (21.9%). PFT indices were significantly correlated with grade and duration of NAFLD, insulin resistance, waist circumference, and hs-CRP. Regression analysis revealed that insulin resistance and hs-CRP were independently associated with decreased PFT indices.
Conclusion: PFT indices were impaired in children with NAFLD and this impairment was independently associated with insulin resistance and hs-CRP.
What is Known: • Pulmonary function tests (PFTs) abnormalities are common in adults with nonalcoholic fatty liver disease (NAFLD). • Studies involving PFTs abnormalities in pediatric NAFLD are lacking. | |
What is New: • It is the first study that assessed PFT in pediatric patients with NAFLD. • PFTs abnormalities are present in children with NAFLD. • Insulin resistance and high sensitive C reactive protein are independently associated with the decline of PFTs in children with NAFLD. |
Similar content being viewed by others
Data availability
Available when required.
References
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231
Lawlor DA, Callaway M, Macdonald-Wallis C, Anderson E, Fraser A, Howe LD, Day C, Sattar N (2014) Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. J Clin Endocrinol Metab 99:E410–E417
Amin S, El Amrousy D, Elrifaey S, Gamal R, Hodeib H (2018) Serum osteocalcin levels in children with nonalcoholic fatty liver disease. JPGN 66(1):117–121
Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V (2012) Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med 44:29–40
Perticone M, Cimellaro A, Maio R, Caroleo B, Sciacqua A, Sesti G, Perticone F (2016) Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients. Int J Mol Sci 17(4):456
Temple JL, Cordero P, Li J, Nguyen V, Oben JA (2016) A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 17:947
Holterman A, Gurria J, Tanpure S, DiSomma N (2014) Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Semin. Pediatr Surg 23:49–57
El Amrousy D, El-Afify D (2020) Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine 135:155215
Mantovani A, Byrne CD, Bonora E, Targher G (2018) Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care 41:372–382
Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 65:589–600
Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62:S47–S64
Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 59:1772–1778
Nigam P, Bhatt SP, Misra A, Vaidya M, Dasgupta J, Chadha DS (2013) Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. PLoS One 8:e49286
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880
Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Pin I, Neukirch F, Zureik M (2006) Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 100:2112–2120
Kwon CH, Rhee EJ, Song JU, Kim JT, Kwag HJ, Sung KC (2012) Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men. Cardiovasc Diabetol 11:38
Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L (2003) Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 253:574–581
Kwak M, Kim E, Jang EJ, Lee C (2018) The association of non-alcoholic fatty liver disease with lung function: a survey design analysis using propensity score. Respirology 23:82–88
Jung DH, Shim JY, Lee HR, Moon BS, Park BJ, Lee YJ (2012) Relationship between non-alcoholic fatty liver disease and pulmonary function. Intern Med J 42:541–546
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
Shannon A, alkhouri N, Carter –Kent C, Monti L, Lopez R, Feldstein AE, Nobili V (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. JPGN 53 :10-195.
Al Biltagi M, Bediwy AS, Toema O, Al-Asy HM, Saeed NK (2020) Pulmonary functions in children and adolescents with sickle cell disease. Pediatric Pulmonology 55:2055–2063
Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP et al (2005) Standardization of the measurement of lung volumes. Eur Respir J 26:511–522
Pellegrino R (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
Qin L, Zhang W, Yang Z, Niu Y, Li X, Lu S, Xing Y, Lin N, Zhang H, Ning G, Fan J, Su Q (2017) Impaired lung function is associated with nonalcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord 17:18
Peng TC, Kao TW, Wu LW, Chen YJ, Chang YW, Wang CC, Tsao YT, Chen WL (2015) Association between pulmonary function and nonalcoholic fatty liver disease in the NHANES III study. Medicine (Baltimore) 94:e907
Leone N, Courbon D, Thomas F, Bean K, Jego B, Leynaert B, Guize L, Zureik M (2009) Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 179:509–516
Takamura T, Misu H, Ota T, Kaneko S (2012) Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr J 59:745–763
Lazarus R, Sparrow D, Weiss ST (1998) Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the normative aging study. Eur Respir J 12:641–645
Kato K, Takeshita Y, Misu H, Zen Y, Kaneko S, Takamura T (2015) Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. J Diabetes Investig 6:158–163
Barzilay JI, Cotsonis GA, Walston J, Schwartz AV, Satterfield S, Miljkovic I, Harris TB (2009) Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged ≥70 years. Diabetes Care 32:736–738
Gariani K, Philippe J, Jornayvaz FR (2013) Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 39:16–26
Takamura T, Misu H, Ota T, Kaneko S (2012) Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr J 59:745–763
Skogstad M, Kjaerheim K, Fladseth G, Gjolstad M, Daae HL, Olsen R, Molander P, Ellingsen DG (2006) Cross shift changes in lung function among bar and restaurant workers before and after implementation of a smoking ban. Occup Environ Med 63:482–487
Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 59:574–580
Qin L, Yang Z, Zhang W, Gu H, Lu S, Shi Q, Xing Y, Li X, Li R, Ning G, Su Q (2015) Association between metabolic syndrome and lung function in middle-aged and elderly Chinese individuals. Diabetes Res Clin Pract. 108:e46–e48
Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, Khaw KT (2004) Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 159:1140–1149
Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, Cassano PA, Iacoviello L, Schünemann HJ (2006) Pulmonary function and abdominal adiposity in the general population. Chest 129:853–862
Author information
Authors and Affiliations
Contributions
D.E., S.G., and S.H. collected the study data, wrote, revised, and approved the manuscript. H.E. and S.M. performed the statistical analysis, collected the study data, wrote, revised, and approved the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Local ethics committee of Faculty of Medicine, Tanta University, approved the study. The study is in accordance with the ethical standards of institutional research committee and with the 1964 Helsinki declaration and its later amendments.
Consent to participate
An informed consent was obtained from the parents of all subjects of the study before enrollment.
Consent to publication
All the authors transfer, assign, or otherwise convey all copyright ownership, including any and all rights exclusively to the journal, in the event that such work is published by the journal.
Conflict of interest
The authors declare that they have no conflict of interest.
Code availability
Not applicable.
Additional information
Communicated by Peter de Winter
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
El Amrousy, D., El Ashry, H., Maher, S. et al. Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease. Eur J Pediatr 180, 1693–1699 (2021). https://doi.org/10.1007/s00431-021-03941-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-03941-3